Kazuki Ikai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kazuki Ikai has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Takayoshi Sakai
Department of Oral-facial Disorders, Graduate School of Dentistry, The University of Osaka, 1-8 Yamadaoka, Suita, Osaka, 565-0871, Japan
2 shared publications E Matsumura Ai
Department of Oral-Facial Disorders, Osaka University Graduate School of Dentistry, Suita-city, JAPAN
1 shared publicationE Takai
Department of Oral-Facial Disorders, Osaka University Graduate School of Dentistry, Suita-city, JAPAN
1 shared publicationH Fukatsu
Department of Oral-Facial Disorders, Osaka University Graduate School of Dentistry, Suita-city, JAPAN
1 shared publicationH Minagi Ono
Department of Oral-Facial Disorders, Osaka University Graduate School of Dentistry, Suita-city, JAPAN
1 shared publication- Hitomi Ono Minagi
Department of Cytology and Histology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan
1 shared publication
Latest Publications
- Open Access
- 4 August 2020
- Published by Wiley in FEBS Letters
- Vol. 594 (19) , 3216-3226
ΔNp63 is upregulated during salivary gland regeneration following duct ligation and irradiation in mice
The transcription factor p63, a component of the p53 family, has important functions in development, homeostasis, and regeneration of epithelial tissues. However, the role of p63 in the regeneration of exocrine glands, including the salivary glands (SGs), has not been fully investigated. We investigated p63 expression in SG regeneration induced by duct ligation and irradiation. The expression of ΔNp63, a p63 isoform, increased and was colocalized with keratin 5 positive cells were myoepithelial cells. Furthermore, ΔNp63 expression was regulated by FGF7 stimulation via p38 MAPK phosphorylation and affected SG morphogenesis. These results suggest that ΔNp63 is essential for SG regeneration and may be a new target for regenerative treatment.
- 4 August 2020
- Published by Wiley in FEBS Letters
- Vol. 594 (19) , 3216-3226
Open AccessΔNp63 is upregulated during salivary gland regeneration following duct ligation and irradiation in mice
The transcription factor p63, a component of the p53 family, has important functions in development, homeostasis, and regeneration of epithelial tissues. However, the role of p63 in the regeneration of exocrine glands, including the salivary glands (SGs), has not been fully investigated. We investigated p63 expression in SG regeneration induced by duct ligation and irradiation. The expression of ΔNp63, a p63 isoform, increased and was colocalized with keratin 5 positive cells were myoepithelial cells. Furthermore, ΔNp63 expression was regulated by FGF7 stimulation via p38 MAPK phosphorylation and affected SG morphogenesis. These results suggest that ΔNp63 is essential for SG regeneration and may be a new target for regenerative treatment.
- Open Access
- 27 April 2018
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 41 (suppl_1) , A207
0555 The Efficacy Of Nasal Airway Stent (nastent) On Obstructive Sleep Apnea And Prediction Of Treatment Outcomes
We performed a prospective study to evaluate the efficacy of nasal airway stent (Nastent) treatment, a nasopharyngeal stent that maintains the patency of the nasal airway to the nasopharynx and oropharynx during sleep, and examined predictors for Nastent treatment outcomes in patients with obstructive sleep apnea (OSA). Thirty patients were enrolled in this study. Cephalometric radiographs were obtained to analyze the craniofacial morphology at baseline. Before and after Nastent treatment, we evaluated OSA using a portable sleep study and Epworth Sleepiness Scale (ESS). Twenty-nine subjects completed this study. There were significant decreases in the apnea hypopnea index (AHI) (22.4 ± 14.1 to 15.7 ± 10.4, p<0.01), CT<90% (2.3 ± 3.9 to 0.4 ± 0.7, p<0.05), and ESS (12.1 ± 4.3 to 6.7 ± 4.0, p<0.01), and a significant increase in the lowest SpO2 (81.9 ± 7.5 to 86.6 ± 4.8, p50% compared with baseline AHI. We evaluated the ratio of inferior airway space and middle airway space (IAS/MAS) on cephalograms as the index of the narrowest airway site. The IAS/MAS was significantly higher in responders than in non-responders (1.4 ± 0.9 vs. 0.9 ± 0.4, p<0.01) and predicted treatment responders with high accuracy (sensitivity: 90.9%, specificity: 88.9%, when IAS/MAS was set at 1.10). The Nastent device improved OSA, and cephalograms predicted treatment response with good sensitivity and specificity. Support (If Any):
- 27 April 2018
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 41 (suppl_1) , A207
Open Access0555 The Efficacy Of Nasal Airway Stent (nastent) On Obstructive Sleep Apnea And Prediction Of Treatment Outcomes
We performed a prospective study to evaluate the efficacy of nasal airway stent (Nastent) treatment, a nasopharyngeal stent that maintains the patency of the nasal airway to the nasopharynx and oropharynx during sleep, and examined predictors for Nastent treatment outcomes in patients with obstructive sleep apnea (OSA). Thirty patients were enrolled in this study. Cephalometric radiographs were obtained to analyze the craniofacial morphology at baseline. Before and after Nastent treatment, we evaluated OSA using a portable sleep study and Epworth Sleepiness Scale (ESS). Twenty-nine subjects completed this study. There were significant decreases in the apnea hypopnea index (AHI) (22.4 ± 14.1 to 15.7 ± 10.4, p<0.01), CT<90% (2.3 ± 3.9 to 0.4 ± 0.7, p<0.05), and ESS (12.1 ± 4.3 to 6.7 ± 4.0, p<0.01), and a significant increase in the lowest SpO2 (81.9 ± 7.5 to 86.6 ± 4.8, p50% compared with baseline AHI. We evaluated the ratio of inferior airway space and middle airway space (IAS/MAS) on cephalograms as the index of the narrowest airway site. The IAS/MAS was significantly higher in responders than in non-responders (1.4 ± 0.9 vs. 0.9 ± 0.4, p<0.01) and predicted treatment responders with high accuracy (sensitivity: 90.9%, specificity: 88.9%, when IAS/MAS was set at 1.10). The Nastent device improved OSA, and cephalograms predicted treatment response with good sensitivity and specificity. Support (If Any):